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Abstract 
We describe a decision support toolkit that was developed with the aim of assisting those 
responsible with the management and treatment of Parkinson’s disease (PD) in the UK. 
Having created a baseline model and established its face validity, the toolkit captures the 
complexity of PD services at a sufficient level and operates within a user friendly 
environment, that is, an interface was built to allow users to specify their own local PD 
service and input their own estimates or data of service demands and capacities. The main 
strength of this decision support tool is the adoption of a team approach to studying the 
system, involving six PD specialist nurses across the country, ensuring that variety of views 
and suggestions are taken as well as systems modelling and simulations. The tool enables key 
decision makers to estimate the likely impact of changes, such as increased use of community 
services on activity, cost, staffing levels, skill-mix, and utilisation of resources.  
Such previously unobtainable quantitative information can be used to support business cases 
for changes in the increased use of community services and its impact on clinical outcomes 
(disease progression), nurse visits and costing.  
 
Keywords: Discrete even simulation, decision support toolkit, Parkinson’s disease, patient 
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1. Introduction 
 
Parkinson’s disease (PD) is the second most common chronic neurodegenerative condition in 
older people especially beyond the age of sixty (De Rijk, et al. 1997).  The diagnosis has 
profound implications for the individual and their family, as well as major cost implications 
for health and social services. Recent estimates show that there are 127,000 people in the 
United Kingdom (UK) living with the disabling effects of Parkinson’s, a number expected to 
increase to 165,000 by 2020 (Parkinson's UK 2011).   
 
The symptoms of Parkinson’s disease can be split into motor and non-motor.  Motor 
symptoms, which are more obvious and tend to be the first to be noticed, include stiffness and 
tremor leading to lack of mobility. Non motor symptoms such as depression, psychotic 
symptoms, dementia, sleep disturbance, fall, and autonomic disturbances, are also 
problematic.  These symptoms tend to occur first, but often go unnoticed due to the difficulty 
in making a definitive diagnosis of PD (Parkinson's UK 2012).  
 
There are four known stages of PD (Parkinson's UK 2012): 1) diagnosis phase is when first 
recognition of symptoms and signs are observed, however diagnosis is not yet established, 2) 
maintenance phase is when diagnosis has been established and where team of experts notice 
absence of postural instability, 3) complex phase is when a patient has unstable co-
morbidities, and 4) palliative phase is when a patient has advanced comorbidity.  In the UK, 
maintenance and complex stage patient’s accounts approximately for a half and a third of the 
PD population, respectively (Parkinson's UK 2012) (around 14% is at the diagnosis stage and 
3% palliative although figures may vary geographically, e.g. rural vs. urban areas).    
 
The treatment of PD is complex and resource intensive, requiring a multi-disciplinary team 
including neurological physicians, general practitioners (family doctors), specialist nurses, 
physiotherapists, speech therapists, occupational therapists and palliative care specialists. 
Coupled with an increasing PD population, it is no surprise that health care systems around 
the world find the management of such patients more and more challenging. In England in 
particular, the National Health Service (NHS) is faced with additional pressures stemming 
from ever increasing resource and capacity constraints (e.g. reduction in budgets, fewer 
doctors and nurses, reduced number of hospital beds, etc.). In general the NHS faces an 
unprecedented resource challenge: net savings of £20 billion must be achieved over the 
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coming 4-5 years, representing a productivity improvement challenge of around 4% a year 
(Chris 2010). Therefore, hospitals and commissioners (payers) of health services need to find 
effective and efficient ways of delivering services to achieve the best outcomes for PD 
patients who need care and support at all times. The key question is where and how to make 
changes to ensure that care and support are delivered in an efficient and effective manner. 
Not surprisingly, the answer is not that simple.  
 
Each individual patient’s requirement depends on the severity and stage of their condition. 
Some could be seen by neurologist on a monthly basis, while others quarterly; Parkinson’s 
specialist nurses may see some patients once a month, whereas others twice a year; in 
addition, PD patients are generally referred to a combination of community services (CS) 
depending on the stage of their disease, such as physiotherapy, psychiatry, speech and 
language therapy, occupational therapy, dietician and palliative care.  Physiotherapy can 
improve balance and flexibility; improve functional independence, including mobility and 
activities of daily living. Occupational therapy improves personal self-care activities, such as 
eating, drinking, washing and dressing; maintain work and family roles, employment, home 
care and leisure activities. Speech and language therapy optimises speech intelligibility, 
ensuring an effective means of communication throughout the course of the disease. 
Therefore, effective deployment of community services is considered to be key in improving 
quality of life and increase patients understanding of their own disease journey, while 
empowering patients to better self-manage their own condition. 
 
The evidence to support the use of community services in PD is limited and yet patients feel 
that it is effective (NICE 2006). At the same time, it is thought that increased use of 
community services could potentially reduce unnecessary hospital admissions, reduce the 
need for consultations with specialists and facilitate the earlier discharge of patients from 
hospital with support in the community (NICE 2006). In many cases, commissioners would 
prefer more use of primary care in the community as opposed to secondary care provided in 
hospitals, simply because primary care is generally much cheaper than secondary care. For 
instance, the average unit cost of a PD patient admitted to inpatient care as an emergency 
admission is £2,133 (based on an average length of stay of 6.3 days) and the average unit cost 
of neurologist visits is around £145. In contrast, units costs associated with community 
services are in the region of £38-£98 (e.g. physiotherapy £38, occupational therapy £56 and 
speech and language therapy £98) (Department of Health 2012).  
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Such a complex care system of possible interactions between PD patients and a variety of 
services and care givers makes it challenging for planners and decision makers to come up 
with better ways of providing the appropriate treatment at the right time and in an efficient 
manner. Thus the need for a decision support tool that captures the complexity in the system 
at a sufficient level and is user friendly such that it can be easily understood and manipulated 
by end users. The tool should respond to the concerns of these end users and enable them to 
achieve a better understanding of the system structure and operations and how these influence  
key performance metrics, such as activity results (e.g. the number of patients treated per 
year), resource utilisation levels (e.g. neurologist, nurses, and beds) and clinical and cost 
outcomes (e.g. disease progression). In this context, the tool should accommodate the 
playing-out of a range of policies and scenarios relevant to decision makers and allow testing 
of the possible impact of these scenarios on the care system performance indicators.  
 
The current study has two objectives. First, to explore the impact of a range of changes to the 
Parkinson’s disease pathway using discrete event simulation (DES) and to explore the utility 
of this approach in this setting. Secondly, to develop a user friendly decision support toolkit 
(a further development on the DES model) with relevant simulation controls. The objective 
here is to get users to interact with the model by enabling them to make necessary changes to 
the input parameters, so that the model is service specific with a customized set of results, 
focusing on activity, costing, resource utilization and disease progression (a proxy measure of 
clinical outcome). These indicators are thought to be valuable for key decision makers in the 
process of commissioning and re-designing services.  
 
 2. Choosing the modelling approach 
The patient flow model within the decision support tool can be developed in a number of 
ways, including using 1) a statistical framework, 2) system dynamics modelling, and 3) 
discrete event simulation (either with the process-centric or agent-based approach). The 
statistical approach would capture the flow of individual patients through the process of care, 
where patient frailties are modelled as random effects. System Dynamics (SD) modelling 
focuses on aggregate flows of patients and the feedback effect that may be present in the 
system and the effects of time delays and non-linear relationships between these flows. 
Discrete event simulation (DES) has the ability to model individual patients and their unique 
trajectories as they flow through the care system and to incorporate a large number of 
different patient attributes such as age, gender and disease stage. It allows for the running of 
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the model over extended time horizons. Patients move through the model and they can 
experience events at any discrete point in time. Moreover, DES provides the flexibility to 
incorporate capacity and resource constraints explicitly and to capture the “competition” 
between competing modelled entities for access to limited resources. 
 
Although capturing physical patient pathways can be immensely useful to better understand 
the major drivers of a system (i.e. reduce inefficiencies, improve patient experience, reduce 
cost), there are three shortcomings towards the implementation of the statistical framework, 
including data related to tracking individual patient pathways and outcomes longitudinally 
over the full care cycle may not be available or when there is a very large number of 
observations and pathways/outcomes to consider.  
 
Similarly, SD is appropriate when the focus is on the high level aggregated elements of a 
system where the interest is on the general patterns of a system’s behaviour over an extended 
period of time. In this particular context, the level of detail at which the PD care system needs 
to be represented will be extremely difficult to represent through an SD model. Discrete event 
simulation also has drawbacks such as the need for more and finer grained values for input 
parameters, longer model implementation times and increased computational costs associated 
with running experiments. However the need to track individual patient journeys (or 
trajectories) through the care system, the ability to capture the complex web of interactions of 
patients going through the diagnosis stage to various forms of treatment that is informed by 
the disease progression of each simulated patient, and the need to model notions of limited 
availability of resources (such as care givers’ time) have motivated us to select DES. 
 
2.1 Discrete-event simulation in healthcare 
DES has been commonly used in health management especially since the 1990 due to the 
increased complexity of health care systems, the shift to more evidence based decision making 
in the health sector, and the significant improvements in DES software capabilities and ease of 
use. These applications have been first reviewed by England and Roberts (1978), who surveyed 
92 models covering areas such as laboratory studies and emergency services. This was 
followed by Klein et al (1993), who presented a review of the use of DES and System Dynamics 
(SD) in health care management with a focus on medical and operational decision making and 
health planning. Similarly, Jun et al (1999) analysed the use of DES in health care in single and 
multi-facility clinics such as outpatient clinics, emergency departments, and surgical centres 
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and  areas such as  patients scheduling and admission,   scheduling and availability of resources,  
bed and staff sizing and planning. More recently, Gunal and Pidd (2010) conducted a review 
on health care performance using DES and describe models related to Accident & Emergency 
(A&E) services, inpatient services, outpatient clinics, specialised hospital units, and hospital 
admission services.  
 
 Many of the studies reported in these reviews relate to patients flows modelling. In this 
context, Swisher et al. (2001) developed a DES model to study the performance of a physician 
clinic in one of the towns in the United States. The model represented the layout and the stages 
patients go through in the clinic, the categories of resources required for the treatment of 
patients, and the types of medical conditions treated. Several scenarios were tested regarding 
staffing levels and facility size and how they affect the financial performance of the clinic, and 
patients and staff satisfaction. In another study by Brailsford and Schmidt (2003), the 
behavioural aspects of patients were integrated into a DES model representing the screening of 
diabetic retinopathy in the United Kingdom (UK). The disease affects the human sight and may 
lead to blindness, hence the importance of the screening process. The model included the 
physical and behavioural factors affecting screening attendance compliance of patients and was 
used to test 10 different behavioural scenarios with the aim to determine the number of total 
years of sight saved over a 25 years period.  
 
The evaluation of policies to prevent mother to child HIV transmission in developing countries 
was studied by Rauner et al (2005). In this context, a DES model incorporating the time related 
evolution of female populations including birth, aging, pregnancy, and giving of birth was 
linked with the progression of HIV and its treatment. The model was calibrated with data from 
Tanzania and used to evaluate policies to prevent transmission of HIV from mother to child. 
The model was run for a 12 years period in order to determine the number of HIV/AIDS deaths, 
which could be prevented. Pligrim et al (2009) built a DES model to evaluate the cost 
effectiveness of care options for patients with bowel cancer in the UK. The model portrayed 
the patients’ flows through a comprehensive care pathways structure including patient 
presentation, referral and diagnosis, treatment, follow up, possibility of recurrence, treatment, 
and end of life. The model was used to evaluate 13 care options recommended by the English 
Bowel Cancer Advisory Committee as possible areas of service improvement and their impact 
on incremental life years gained, quality adjusted life years, and the cost per life year gained. 
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In this study, we involved health care professionals and potential end-users from the outset. 
The modelling requirements were developed following semi-structured interviews and group 
meetings with 6 PD specialist nurses. We used simulation software known as SIMUL8 
(http://www.simul8.com/), which enabled us to design and implement a user friendly 
graphical interface with simulation controls for end users.  Therefore, in this work we 
developed a DES model for better management of PD pathway with simulation controls and a 
graphical user interface. Users could easily specify their demand levels, make assumptions 
related to all aspects of patient pathways; specify the scenarios to compare against; state the 
allocation of resources (e.g. nurses, neurologist); and specify disease progression from one 
disease category to another (e.g. complex to palliative care). The results are then illustrated in 
two formats, a reduced custom report with key performance metrics and a detailed 
breakdown of model outputs exported to Microsoft Excel spread sheet, where two sets of 
scenarios can be compared against each other.  
 
3 Material and methods  
3.1 High level description of the decision support tool 
This PD simulation was developed to be used nationwide by a major pharmaceutical 
company to facilitate service change in the UK with the aim of benefiting patients, the 
healthcare provider and the company who also supply some of the drugs used in the pathway. 
As the envisaged end users were not meant to be simulation experts we designed and 
implemented from the outset a graphical user interface to facilitate the running of the 
simulations by non-experts and without the need for retorting to the research team for future 
experimentation. Figure 1 shows a high level representation of the resultant simulation-based 
decision support tool for informing the management of patients with Parkinson’s disease. The 
tool is made up of six sets of key inputs (identified at the conceptualisation phase) and four 
sets of key outputs which are considered to be the key performance indicators of the system’s 
operation. The tool comes pre-populated with values for all the input parameters as these 
were estimated through the structured interviews we had with the six PD specialist nurses and 
the analyses of the national English hospital episodes statistics dataset. The end users 
however are able to change the values of the input parameters (see Table 1 for details) 
according to the configurations of their local services. Two sets of input parameters can be 
entered namely scenario 1 (baseline model) and scenario 2 the experiment (or intervention). 
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The scenarios are then compared with respect to key performance indicators (i.e. activity, 
costs and staff utilization). 
Internally, the model captures various patient categories flowing through PD services 
including individual progression from diagnosis, treatment and disease states, to community 
services.  
<<<<< Place Figure 1 here >>>>>>> 
3.2 Additional setting description  
The first stage of the pathway mapping was a round table meeting held with the national 
committee of the Parkinson’s Disease Nurse Specialist Association (PDNSA) in November 
2012 (PDNSA n.d.).  The PDNSA is based in the UK and was established in 1999 to act as an 
international resource and network for specialist nurses and allied healthcare professionals 
working in the field of Parkinson’s disease management. The PDNSA is autonomous but 
collaborates closely with other organisations to promote the role of the Parkinson’s Nurse 
Specialist, and to provide developmental opportunities, education and support. The round 
table meeting consisted of structured conversation coordinated by the authors. The objective 
was to explore the PD pathway in order to establish what in the experts’ opinion were 
important areas for development.  
 
The second phase of the pathway mapping consisted of structured interviews with members 
of the PDSNA national committee and other influential PD nurses between January and 
March 2013. The interviews were conducted ‘on line’ using WebEx technology to allow the 
interviewer to share a working diagrammatic representation of the pathway. The interviewer 
discussed each stage of the pathway with the interviewee taking account of the interviewee’s 
opinion and adjusting the pathway in ‘real time’ as comments were made. The involvement 
of the model user in model construction ensured that a high degree of realism is built into the 
model through reasonable assumptions regarding system structure. Once the interviewee was 
satisfied with the structure of the pathway the interview was closed. The interviews were 
recorded so that the interviewer could review comments after the event to ensure that all 
salient points had been captured.  In total six experts were interviewed iteratively (see Figure 
2 for the finalised pathway mapping of PD). 
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PD comprises a complex set of services offered in and out of hospital (i.e. in the community). 
According to the interviews conducted, the typical care system in England involves 
diagnostic, treatment and monitoring activities. Typically patients first present (or arrive) to a 
PD outpatient clinic via referral from their GP, accident and emergency (A&E), other 
hospital department (e.g. care of the elderly), or from other services. At this stage (i.e. 
diagnosis - top half of Figure 2), if PD is suspected by a consultant, further diagnostic tests 
are carried out by a secondary care specialist (i.e. neurologist) in the form of medication 
(known as PD medication) and/or the imaging of the brain (advanced diagnostic imaging) by 
a radiographer. A PD medication can be administered at the stage of diagnosis to see if there 
are improvements in symptoms of PD, which could enable the specialist to rule signs of PD. 
If PD is diagnosed, patients are categorised depending on the stage of their disease 
(diagnosis, maintenance, complex or palliative) and treatment commences, typically within 1-
4 weeks of being diagnosed.   
 
Having being diagnosed of PD, patients move into the treatment part of the pathway (bottom 
half of Figure 2). Initial treatment is usually carried out by a secondary care specialist, where 
the patient can be referred to surgery (on a very small number of cases), pharmacological 
management or community services (e.g. physiotherapy, occupational therapy, speech and 
language therapy, palliative care and dietician). Parkinson’s specialist nurses play a crucial 
role at this stage in managing and determining the needs of PD patients. Therefore, both the 
specialist and PD specialist nurses are involved in the treatment process. The details of the 
organisation of care into and around these two activities and further into community services 
depends on the service provider. For example, in certain localities some providers may make 
more of use community services than elsewhere.  
 
Pharmacological management is carried out by the specialist and a PD specialist nurse. 
Patients in the diagnosis, maintenance, complex and palliative care stage of disease are 
reviewed 2, 4, 5 and 6 times in a year, respectively. At the review consultation the possibility 
of disease progression is evaluated and decisions about escalating the treatment regimen (e.g. 
from maintenance to complex) are made.  Primary care (or community services) is more 
complex and decided upon the needs of patients, hence the percentage of patients routed out 
to a particular community service varies considerably between PD services.  
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Note that, each individual patient’s trajectory through the four known stages of Parkinson’s 
disease influences to a large extent the type, location and intensity of care services in each 
individual’s care package. Thus, a decision support tool designed to help planners and 
managers set-up and run such a complex care system should take into account the 
organisation, availability and cost of care services but also the number of patients and the 
stage in the disease progression each patient within the care system is.  
 
<<<<< Place Figure 2 here >>>>>>> 
 
3.3 Model building including assumptions  
As it is the case in modelling studies, some aspects of the real life service were not included 
in the model (if they were not relevant to the objectives of the study) and others were 
modified for simplification purposes.  These were discussed and agreed upon by the nurses 
and specialists who were consulted during the model building process. The capacity relevant 
to the study was mostly related to the telephone interviews we had with six Parkinson’s 
disease specialist nurses. Other staff specialties (e.g. administrative clerks, other specialists 
that were not included) and infrastructure elements (e.g. consultation rooms, mode of 
transportation used for community visits) that could be seen as capacity constraints were not 
included in the model as these were not seen as critical by the stakeholders. There are no 
cancellations (either patient or service initiated) of outpatient consultations or community 
based visits. Death in the model only occurs from the palliative stage and is related to PD 
(Robinson 2004). The presence of co-morbidities and other factors, such as socio-economic 
status or living arrangements, that may complicate the provision of care for a particular 
patient were not included in the model. 
 
3.4. Input parameters  
Model inputs included staffing levels, staff salary, staff availability, treatment pathways 
(hospital and the community), percentage of patients falling into each category, year on year 
percentage increase in arrivals, costing of each service, existing and new patient arrivals and 
disease progression parameters (see Table 1 for details). The vast majority of input 
parameters are user specified and in a number of occasions the parameter values are 
estimated using data from the national Hospital Episodes Statistics (HES). Where data is 
available appropriate estimates are provided for guidance but the user may change as and if 
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required. The HES dataset contains personal, medical and administrative details of all 
patients admitted to, and treated in, NHS hospitals in England.  
The justification for allowing the values of input parameters to be user defined is because of 
the wide variation between and within services across the country. For example, the number 
of patients within a service varies dramatically, with some services having less than a 1000 
patients, whereas others having more than 2000. In this case, the tool calculates the average 
number of arrivals per day (based on 5 days a week Monday – Friday, 9:00am – 17:00pm) 
which then becomes the parameter for the Poisson distribution. Again, using the HES dataset 
we provide the number of existing PD patients within the service provider (NHS Trust) or 
Clinical Commissioning Group (CCG) and if the figure is not appropriate for the analysis 
users may change accordingly. CCGs are groups of General Practitioners and from April 
2013 they will be responsible for commissioning and designing local health services in 
England. 
 
A typical percentage of patients falling into each category (i.e. patient type) are as follows: 
10% diagnosis, 60% maintenance, 25% complex and 5% palliative care. The average 
percentage of patients presenting to the service via GP, A&E, outpatients and other hospital 
department are 75%, 15%, 5%, and 5%, respectively. The number of times patients seen by 
neurologist and PD nurses each year by service providers do not change significantly. 
Typically, a new diagnosed patient would normally be seen by a neurologist once a year and 
few times by PD nurses in between, whereas maintenance category patients would be seen 
every 3-6 months, complex patients every 4-6 months, and a care plan would be prepared for 
palliative patients, possibly seen by the nurse once a month.  
 
Unfortunately, there is very little data or knowledge about the use of community services and 
based on the interviews we had with PD specialist nurses, there is large variation in their 
responses about the utilisation of such services. Therefore the tool first asks users to specify 
the percentage of patients within their population that are referred to community services by 
type of service. Secondly, from those patients that are referred to a combination of 
community services, we then ask users to specify the number of times (i.e. follow-ups) each 
patient type are seen by a physiotherapist, psychiatrist, speech and language therapist, 
occupational therapist, palliative care nurse, and a dietician (per year).  
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In addition, questions surrounding resource requirements are also asked. A specialist or PD 
nurse may also refer a patient to a community service and a resource is attached for each 
referral, e.g. physiotherapist, psychiatrist, occupational therapist, speech and language 
therapist and dietician. To address this complexity we ensured that the numbers of resources, 
percentage of patients routed out to a particular community service, follow-ups, etc. are all 
user defined. Note that there are limited numbers of specialists, PD nurses and community 
workers within the PD services, hence this is a limited capacity simulation. 
 
The next set of input parameters relates to disease progression. A limitation associated with 
this parameter is the lack of data availability to capture the relevant distribution and 
parameter estimates for each transition (e.g. diagnosis to maintenance). When data is not 
available the triangular distribution is typically used in many simulation studies (Robinson 
2004) as the parameters are fairly straightforward to elicit: in this case, the minimum, average 
and maximum number of years (or months) it takes for a patient to move from one disease 
category to another. Again users would need to specify these parameters according to the 
disease progression within their PD population, that is, patients moving from one stage to 
another, e.g. maintenance to complex.  
 
We established the unit costs of PD patients who have attended A&E and discharged for 
inpatient care using the Healthcare Resource Group (HRG) code.  This included the unit cost 
of the HRG and any payments due because of an unexpectedly long stay in hospital, or for 
any specialist care or additional treatments and tests (so-called unbundled payments). We 
also calculated outpatient and community service costs using their corresponding HRG codes.  
The HRG codes and their associated costs are publicly available at Department of Health 
website under Reference Costs for 2012-13 (see (Department of Health 2012) for details).  
 
The final sets of parameters are staff salary and the number of available staff. Staff salaries 
are selected from a drop down list. The numbers of available staff are defined by the user.   
 
<<<<< Place Table 1 here >>>>>> 
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4 Illustrative results 
 
 4.1 Simulation parameters 
 
For illustration purposes of the model and the tool, we chose to evaluate the likely effect size 
of some changes that seek to increase the use of community services, in line with current 
policy guidance for PD patients. The number of patients requiring treatment, which 
determines the level of demand on care services is not constant over time, but has an upward 
trend. The model captures this aspect through the year to year percentage increase in number 
of patients in the service. The data collected from the services studied in this project that 
these percentages are 5% at the end year 1, 3.5% at the end of year 2, and 6.5% at the end of 
year 3 leading to a total cohort size of 1211 patients by the end of year 3. Among these 
patients, 10% belong to the Diagnosis category, 60% to the Maintenance category, 20% to 
the Complex category, and 10% to the Palliative category. With regard to the number of 
nurse visits there are 2, 3, 4, and 6 visits on average per year for the Diagnosis, Maintenance, 
Complex, and Palliative groups, respectively. The model was populated with a cohort size of 
1000 patients at the beginning of year 1. 
 
 
The level of utilisation of the different types of community services, represented by the 
fraction of PD patients directed to these services, was confirmed by experienced nurses and  
consultants. This analysis suggested that on average 42.5% of patients are directed to speech 
and language therapy, 35% to occupational therapy, 22.5% to psychiatry services, 7.5% for 
dietician, 7.5% to palliative care, and 45% to physiotherapy. The model was run for 3 years 
with a warm up period of 1 year (determined using the Welch method) to make sure that 
results are not collected until all patients in the cohort have gone through the PD care system 
and had an initial contact with a nurse, secondary care worker, or a community service. The 
weekly simulation period is Monday to Friday from 9am to 5pm reflecting the current 
operating arrangements in the PD care services. 
 
 4.2 Model validation 
 
The model validation process was carried out by comparing the expected number of nurses 
and consultants visits over a 3-year period using the known data in the actual care system 
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with the simulation results. As described in the previous section, the cohort size is expected 
to reach 1211 by the end of year 3. The total number of visits over a 3-year period was 
calculated taking into account the total cohort size, the fraction of the PD category, the 
number of visits per year for each category, and the simulation duration of 3 years. As an 
example, the total number of nurse visits for the Diagnosis group is equal to 1150 x 0.1 x 2 x 
3 that is 690 visits over three years (0.1 is the proportion of Diagnosis group patients, 2 is the 
number of nurse visits in a year, and 3 is the simulation period in years). Similarly, for the 
Maintenance group we have 1150 x 0.6 x 3 x 3 = 6210 visits over three years. The 
cumulative number of nurse visits for all PD patients’ categories (including complex and 
palliative) was calculated as 11,730 visits. This compares to an average total number of 
11,106 visits (the 95% lower and upper bounds of the confidence interval are 10940 and 
11210 visits, respectively) generated by the simulation model results, which is different by 
6% from the real world results. 
 
A similar process was used with regard to the total number of consultants’ visits. The results 
generated by the calculations based on real world information were 10, 350 visits for the real 
world, and 9,558 visits generated by the model, that is a difference of 7% (the 95% lower and 
upper bounds of the confidence interval are 9,377 and 9,739 visits, respectively). On this 
basis, the model results were deemed robust to allow experimentation with alternative 
scenarios to take place. 
 
To achieve face validity (whether the model appears reasonable on the face of it), the model 
was shown to each nurse individually and then in a workshop including all six nurses. The 
model structure was confirmed to be highly representative of the real world PD care system 
by all five nurses in the individual meetings and during the workshop where the whole group 
was present. In general, the continuous engagement of the PD nurses throughout the study 
increased significantly the confidence in the validity of the model. 
 
4.3 Experimentation   
 
The aim of the experiment is to assess the possible impact of shifting more PD patients from 
hospital care to community care services. Although there is a belief based on anecdotal 
evidence that this should have a positive impact on the operational and financial performance 
of the PD care system, it is important to support this by stronger evidence including 
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quantification of any benefit of such policy. In this context, the simulation model developed 
in this research was used to evaluate the impact of several scenarios, which reflect the policy 
of patients shifting to community services. 
 
The parameter values of the experiment were determined through a workshop with 
experienced senior nurses and consultants from different PD care units in the UK. The 
participants were asked to come up with estimates of the reduction in average annual nurse 
and consultant visits if the use of community services were to increase by 10% (this value 
was suggested by the participants as the most likely feasible increase in the next three years). 
In order to make the simulation results more realistic, each participant was asked to give three 
estimates of the decreases in the number of visits. Three scenarios were identified from the 
care service providers and these are: pessimistic, realistic, and optimistic. The average 
decrease was 5%, 10%, and 20% for the pessimistic, realistic, and optimistic situations, 
respectively (Table 2). The practical meaning of the figures in Table 2 is that the inter-visits 
interval duration is increased from its current level. 
 
<<<<< Place Table 2 here >>>>>>> 
 
Each simulation was run 100 times (with different random seeds) and each run for 3 years to 
capture the individual trajectories in the cohort over this period and to estimate the likely 
impact of changes on performance indicators related to activity, costs, and utilisation of 
resources (e.g. nurses). Results were collected regarding the activity, cost, and utilisation of 
resources under the three scenarios mentioned above. Specifically, the performance indicators 
used to evaluate the scenarios are “specialist nurse activity (SNA)”, “specialist nurse cost 
(SNC)”, total specialist nurse service hours (TSNH)”, and “total FTE needed for specialist 
nurse (TFTE)”. For each indicator we calculated the mean and 95% confidence interval. A 
summary of the results is presented in Table 3.   
 
<<<<< Place Table 3 here >>>>>>> 
 
The results indicate that increasing use of community services will have a positive impact on 
the specialist nurses level of activity and its associated costs. The level of activity decreased 
markedly for a gain of around 21% (11,106 to 8,708). This is quite significant taking into 
account the fact that nurses in the PD treatment services are highly utilised and under huge 
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workload pressure. There is a noticeable small variation in the CIs and the reason for this is 
that we assumed the number of times a patient sees a PD specialist nurse in a year is fixed 
(according to the interviews we had with the nurses), hence no distributional assumption were 
made on these visits. This small variation is caused by the number of “new” arrivals each 
year during simulation run. When the model was tested to examine the impact on community 
service visits, there is a wide variation between runs, simply because a distributional 
assumption was made (i.e. Poisson). What is important to a tool user is the overall impact of 
these reductions. For example, reducing the visits of “Diagnosis, Maintenance, Complex and 
Palliative” categories from 2, 3, 4 and 6 visits per year to 1.8, 2.7, 3.6 and 5.4, respectively, 
has a dramatic impact on the overall PD nurse visits (11,106 to 8,758). Note that the model 
enables users to run current visits (scenario 1) vs. any number of visits (scenario 2).  
 
The other positive impact of the increased community services policy and its resulting 
decrease in the activity levels of nurses is the reduction of nurses’ costs. In this context, the 
costs saving under the pessimistic, realistic, and optimistic scenarios are £109,800, £157,400, 
and £234,800 respectively. These reductions which vary between 10% under the pessimistic 
scenario and 21% under the optimistic scenario are significant in the PD care services and the 
general health care services, where squeezed budgets and funding cuts are expected to 
become a common feature of the health care landscape in the future. 
 
The reduction in nurses’ activity has also an impact on the number of total hours of specialist 
nurse service. As seen on Figure 3 the number of hours goes down as we move from the 
current to the optimistic scenario. It is interesting to see that the most significant decrease 
occurs when we move from the current to the pessimistic scenario where the number of hours 
drops by around 40% from 8330 hours to 5004 hours and then to 4766 and 4379 hours under 
the realistic and optimistic scenarios. This non-linear reduction is quite interesting as the 
reductions of 5% (current to pessimistic), 5% (pessimistic to realistic) and 10% (realistic to 
optimistic) lead to 40%, 5%, and 8% respectively. These results are very significant, from a 
management perspective, as even the smallest possible reduction in nurses’ visits due to 
increased utilisation of community services appears to lead to substantial reduction in the 
specialist nurses workload (as reflected in the total number of FTEs). The same trend can be 
observed here as the total FTEs decreases by 40% from current to pessimistic, 5% from 
pessimistic to realistic, and by 8% from realistic to optimistic. 
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<<<<< Place Figure 3 here >>>>>>> 
 
 
5 Discussion and Conclusion 
 
The current research addresses a top-of-the-agenda issue in health and social care 
management as it focuses on the policies related to service re-design and how they have an 
impact on the performance of health and social care systems. The importance of the research 
can be appreciated in the current context of increasing demand on health service provision at 
the time when we are moving to the new reality of tighter public finances.  
 
This might mean providers and purchasers of services (i.e. NHS Trusts and Clinical 
Commissioning Groups, respectively) may need to re-design services with increased use of 
community services as opposed to treating patients within a hospital setting, simply because 
this is the way care has been organised over a number of years. Could these changes ensure 
that patients receive the right care at the right time and in the right place? How do we explore 
the impact on different metrics of a range of system changes? Our solution was to construct a 
decision support tool using discrete event simulation with a user friendly interface and 
simulation controls of Parkinson’s disease pathway, calibrated with existing data and expert 
opinions from five nurses ranging from south of England to North with a combined 
experience of 85 years.     
 
The tool allows decision makers to better understand the operation of the system in relation to 
key performance metrics associated with activity, cost implications, resource utilisation 
(neurologist and nurses) and disease progression (a clinical outcome). The ease of use of the 
tool with relevant set of exported results means that senior decision makers could be more 
proactive with evidence based approach in re-designing their care pathway to assist nurses, 
clinicians and commissioners in finding the most efficient and effective delivery of care to 
the elderly with Parkinson’s disease. In this context, the illustrative scenarios tested on the 
tool are a sample of a wider range of policies, which can be evaluated through this DSS. This 
can only be welcomed given the importance of and efficient and high quality healthcare 
delivery for the wellbeing of individuals and society. 
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The simulation results suggest that an increase use of community services will have a positive 
impact on the workload and utilisation of PD specialised nurses. Therefore, the policy 
rationale that making more use of community services to treat and monitor the evolution of 
the PD patients health state and, therefore, alleviate the workload pressures on nurses is 
strongly supported by the simulation results. As such, the simulation based DSS developed 
here is a very good example of the “evidence based decision making” tools, which have 
gained in popularity in the last few years especially within the healthcare management sector. 
It is also a good example of how a DSS can be developed and used in the context of 
integrating health (i.e. in the hospital) and social care (i.e. in the community) systems. 
 
The research has some methodological and contextual limitations. First, the unavailability of 
relevant data about community services meant that we relied on expert opinions and 
judgment, which can be affected by subjective biases. Second, given the lack of data, we 
assumed that disease progression, that is the distribution of patients moving from one disease 
category to another, has a triangular distribution. In addition, we did not take account of co-
morbidities and interactions with other diseases which may impact on the speed of disease 
progression and the associated level of care. The model was built using information from a 
single context, which can “corrupt” the results and reduce confidence in the validity of the 
results and the ensuing policy decisions.   
 
The decision support tool used in this research offers decision makers a powerful tool to 
appreciate the complexity of the PD pathway, understand its inner working, and the 
parameters driving their behaviour and performance. In fact the tool, in addition of providing 
the means for numerical experimentations can also be classified as a ‘tool for thinking’ (Pidd 
2003), enabling key decision makers to challenge their assumptions and see the systems in 
which they operate in a new light. Furthermore, they offer nurses, clinicians and managers 
the opportunity to evaluate the implications of possible policies and actions on the 
performance of their systems before the actions are implemented in the real world, hence 
avoiding the trap of ‘doing things and hoping for the best’. To the best of our knowledge no 
decision support tool at this scale within a simulation environment has been published or 
disseminated for PD pathway modelling.  
 
As described earlier in the paper the tool was designed with the aims of supporting front-line 
staff and managers in testing out the likely impact of suggested changes in the PD patient 
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pathway on a number of key performance indicators. The authors have first-hand experience 
of the frustrations that can sometime accompany planning and approving new services in 
healthcare systems. Often changes are introduced without proper consideration of the impact 
on the service. It is also often the case that those people working in the healthcare system 
know how they would like to improve the service they deliver but lack the expertise to frame 
those improvements in a manner that will allow a strong case to be made to board-level 
executives and holders of budgets. This tool therefore has been designed to allow ‘non-
simulation experts’ to test change on the pathway in a validated simulation that will present 
the impact of changes in a way that can be easily understood by both the executive and 
pathway specialists. It is the intention that this will facilitate service planning and decision 
making and speed up the pace of change in the PD pathway.  Furthermore, the use of 
simulation as a decision making tool is still in its infancy within the healthcare sector in the 
UK. We would therefore recommend that a longer term study on the impact of the PD 
simulation would be helpful. We would suggest following the progress of service 
development projects that use simulation in comparison with those that do not. Such 
simulation tools would also benefit enormously by richer and better quality primary care data 
which would add considerable to the robustness of the assumptions that are used to support 
the simulation. 
 
The decision support tool is currently being used by a major pharmaceutical company to 
facilitate service change in the UK. The simulation is being used nationwide by the 
pharmaceutical company’s healthcare development team with the objective of developing PD 
services for the benefit of patients, the healthcare provider and the company who also supply 
some of drugs used in the pathway. 
 
In conclusion, the study provided previously unobtainable quantitative information which 
could be used to support business cases for changes in the increased use of community 
services and its impact on clinical outcomes (disease progression), nurse visits and costing. 
The main strength of this decision support tool is the adoption of a team approach to studying 
the system, involving five PD specialist nurses across the country, ensuring that variety of 
views and suggestions are taken as well as systems modelling and simulation. This led to a 
model with high face validity and credibility among its users.  
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Table 1 Input parameters. 
Parameter Data Collection Distribution 
Type 
Input data for 
experimentation 
(section 4.3) 
Demand  
Existing patient arrival HES data or 
user specified 
Poisson Existing patient size 
= 1000 
New patient arrival HES data or 
user specified 
Poisson Approximately 50 in 
year 1, 36 in year 2 
and 71 in year 3. 
Percentage of patients falling into each 
category, i.e., diagnosis, maintenance, 
complex and palliative.  
User specified Multinomial Diagnosis = 10%, 
Maintenance = 60%, 
Complex = 20% and 
Palliative = 10% 
Yearly increase over the three year period User specified Multinomial 5%, 3.5% and 6.5%  
Percentage of suspected PD patients User specified Bernoulli 90% 
Percentage of patients presenting through 
General Practitioner 
HES data or 
user specified  
Multinomial 75% 
Percentage of patients presenting through 
A&E 
HES data or 
user specified 
Multinomial 15% 
Percentage of patients presenting through 
Outpatients 
HES data or 
user specified 
Multinomial 5% 
Percentage of patients presenting through 
other hospital department, e.g. care of the 
elderly  
HES data or 
user specified 
Multinomial 5% 
Treatment pathway (in hospital)  
Time between initial outpatient screening 
to a specialist (i.e. neurologist) for first PD 
diagnosis 
User specified Uniform [2, 4] weeks 
Time between first diagnosis to the start of 
treatment  
User specified Uniform [1,4] weeks 
If PD is suspected, what percentage of 
patients is actually diagnosed for PD? 
User specified Bernoulli 90% 
The number of times (in a given year) each 
patient is seen by a Neurologist (by patient 
type). 
User specified Fixed Diagnosis = 1, 
Maintenance = 2, 
Complex = 3 and 
Palliative = 4. 
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The number of times (in a given year) each 
patient is seen by a specialist PD nurse (by 
patient type). 
User specified Fixed Diagnosis = 2, 
Maintenance = 3, 
Complex = 4 and 
Palliative = 6. 
The time it takes for a neurologist to treat 
patients (in minutes) 
User specified Mean 60 minutes 
The time it takes for a specialist PD nurse 
to treat patients (in minutes) 
User specified Mean 60 minutes 
Community services pathway  
Percentage of patients referred to 
community services, i.e., physiotherapy, 
psychiatry, speech and language therapy 
(SLT), occupational therapy (OT), 
palliative care, dietician. 
User specified Multinomial Physiotherapy = 
45%, psychiatry = 
22.5%, SLT = 
42.5%, OT = 35%, 
Palliative = 7.5%, 
Dietician = 7.5% 
The number of times (in a given year) 
patients are referred to physiotherapy (by 
patient type). 
User specified Poisson Diagnosis = 1 
Maintenance = 2 
Complex = 2 
Palliative care = 3 
The number of times (in a given year) 
patients are referred to psychiatry (by 
patient type). 
User specified Poisson Diagnosis = 1 
Maintenance = 2 
Complex = 2 
Palliative care = 3 
The number of times (in a given year) 
patients are referred to speech and 
language therapy (by patient type). 
User specified Poisson Diagnosis = 1 
Maintenance = 2 
Complex = 2 
Palliative care = 3 
The number of times (in a given year) 
patients are referred to occupational 
therapy (by patient type). 
User specified Poisson Diagnosis = 1 
Maintenance = 2 
Complex = 0 
Palliative care = 0 
The number of times (in a given year) 
patients are referred to palliative care (by 
patient type). 
User specified Poisson Diagnosis = 0 
Maintenance = 0 
Complex = 2 
Palliative care = 4 
The number of times (in a given year) 
patients are referred to a dietician (by 
patient type). 
User specified Poisson Diagnosis = 1 
Maintenance = 1 
Complex = 2 
Palliative care = 3 
Disease Progression  
Diagnosis to Maintenance User specified Triangular 
distribution 
[min = 1 year, 
average = 2 years, 
maximum = 4 years] 
Maintenance to Complex User specified Triangular 
distribution 
[min = 2 year, 
average = 3 years, 
maximum = 4 years] 
Complex to Palliative User specified Triangular 
distribution 
[min = 3 year, 
average = 5 years, 
maximum = 7 years] 
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Palliative to Death User specified Triangular 
distribution 
[min = 3 months, 
average = 6 months, 
maximum = 1 year] 
Cost    
A&E attendance including hospital 
admissions 
HRG codes 
(reference costs) 
Mean £2,233 
Neurologist HRG codes 
(reference costs) 
Mean £220 
Imaging HRG codes 
(reference costs) 
Mean £100 
Anti PD Medication User specified Mean Unknown 
Unit cost for PD specialist nurse User specified Mean £150 
Physiotherapy HRG codes 
(reference costs) 
Mean £38 
Psychiatry HRG codes 
(reference costs) 
Mean £50 
Occupational therapy HRG codes 
(reference costs) 
Mean £58 
Speech and language therapy HRG codes 
(reference costs) 
Mean £96 
Palliative care HRG codes 
(reference costs) 
Mean £50 
Salary  
Specialist PD nurse User specified Mean £36,303 
Neurologist User specified Mean £80,810 
Number of resources  
Specialist PD nurse User specified Fixed 5 
Neurologist User specified Fixed 2 
 
 
Table 2: Average nurse visits per year under pessimistic, realistic, and optimistic scenarios 
Visits Current Pessimistic    
(5% decrease) 
Realistic          
(10% decrease) 
Optimistic  
(20% decrease) 
Diagnosis 2 1.9 1.8 1.6 
Maintenance 3 2.85 2.7 2.4 
Complex 4 3.8 3.6 3.2 
Palliative 6 5.7 5.4 4.8 
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Table 3:  The impact of increasing community by 10% on nurse visits and nurse utilisation 
rates, mean values (95% confidence interval).  
Visits Current Pessimistic Realistic Optimistic 
Specialist Nurse Activity 
(SNA) 
11,106 
(10,940 to 
11,210) 
10,008  
(9,830 to 
10,186) 
9,532  
(9,356 to 
9,708) 
8,758  
(8,574 to 
8,942)  
Specialist Nurse Cost 
(SNC) 
£1,110,600  
(£1,094,152 to 
£1,127,148) 
£1,000,800 
(£982,986 to 
£1,018,614) 
£953,200 
(£935,566 to 
£970, 834) 
£875,800 
(£857,408 to 
£894,192) 
Total Specialist Nurse 
Service Hours (TSNH) 
8,330 
(8,206 to 8,454) 
5,004 
(4,911 to 
5,096) 
4,766 
(4,678 to 
4,854) 
4,379 
(4,287 to 
4,471) 
Total FTE Needed for 
Specialist Nurse (TFTE) 
1.803 
(1.776 to 1.830) 
1.083 
(0.998 to 
1.102) 
1.031 
(1.012 to 
1.050) 
0.947 
(0.927 to 
0.967) 
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Figure 1: A high-level representation of the simulation-based decision support tool for 
informing the management of patients with Parkinson’s disease.  
Figure 2: Conceptualised pathway for Parkinson’s disease patients. * Community services 
include Physiotherapy, Psychiatry, Occupational Therapy, Speech and Language Therapy, 
Palliative Care and Dietician. Pharmacological management refers to medication. GP: 
General Practitioner; A&E: Accident & Emergency; PD: Parkinson’s Disease. 
 
Figure 3: Simulation results of the required total specialist nurse service hours (TSNH) for 
each scenario (mean values - 95% CIs are too narrow and were omitted from the Figure). 
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Figure 1  
 
  
Decision Support Tool (user 
interface, simulation engine) 
INPUTS 
Demand for PD services  
Hospital treatment pathway 
Community services pathway 
Disease progression 
Levels of resources 
Costs per unit of resource 
OUTPUTS 
Activity per year per scenario  
 
Total costs per year per scenario  
Specialist/PD nurse utilisation 
rates per year per scenario  
Disease progression 
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Patient presents in 
GP
Suspected PD
Secondary Care 
Specialist 
Diagnosis
Imaging
· Functional
· Structural
PD Diagnosed
Patients presents 
in A&E
Patient presents in 
Out Patients
Other Hospital 
Department
Back to primary 
care
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Other
Diagnosis
Maintenance
Palliative
Complex
 ANTI PD 
Medication
Pharmacological 
Management
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Services*
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Surgery
Treatment
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Treatment starts
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